Clinical Trial Update: A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating amprenavir in combination with other anti-HIV drugs in HIV-positive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Amprenavir (amprenavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED